Patents by Inventor DILJEET S. ATHWAL

DILJEET S. ATHWAL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180371066
    Abstract: Provided herein is an isolated antibody or antigen-binding fragment that specifically binds tau, the antibody or fragment comprising a heavy chain variable (VH) region and a light chain variable (VL) region having amino acid sequences set forth herein. Also provided are methods of preventing or treating a tauopathy in a subject, comprising administering to a human in need of therapy for a tauopathy with one or more antibodies or fragments as described herein, wherein the antibodies or antigen-binding fragments are administered under conditions and in an amount effective to prevent or treat the tauopathy.
    Type: Application
    Filed: March 23, 2018
    Publication date: December 27, 2018
    Inventors: Tim WEST, Diljeet S. Athwal, Timothy D. JONES, Francis J. CARR, Robert George Edward HOLGATE
  • Patent number: 9957317
    Abstract: Provided herein is an isolated antibody or antigen-binding fragment that specifically binds tau, the antibody or fragment comprising a heavy chain variable (VH) region and a light chain variable (VL) region having amino acid sequences set forth herein. Also provided are methods of preventing or treating a tauopathy in a subject, comprising administering to a human in need of therapy for a tauopathy with one or more antibodies or fragments as described herein, wherein the antibodies or antigen-binding fragment are administered under conditions and in an amount effective to prevent or treat the tauopathy.
    Type: Grant
    Filed: September 6, 2016
    Date of Patent: May 1, 2018
    Assignee: C2N Diagnostics, LLC
    Inventors: Tim West, Diljeet S. Athwal, Timothy D. Jones, Francis J. Carr, Robert George Edward Holgate
  • Publication number: 20170058024
    Abstract: Provided herein is an isolated antibody or antigen-binding fragment that specifically binds tau, the antibody or fragment comprising a heavy chain variable (VH) region and a light chain variable (VL) region having amino acid sequences set forth herein. Also provided are methods of preventing or treating a tauopathy in a subject, comprising administering to a human in need of therapy for a tauopathy with one or more antibodies or fragments as described herein, wherein the antibodies or antigen-binding fragment are administered under conditions and in an amount effective to prevent or treat the tauopathy.
    Type: Application
    Filed: September 6, 2016
    Publication date: March 2, 2017
    Inventors: Tim West, Diljeet S. Athwal, Timothy D. Jones, Francis J. Carr, Robert George Edward Holgate
  • Publication number: 20020099179
    Abstract: There are disclosed: a CDR-grafted antibody having at least one chain wherein the framework regions are predominantly derived from a first antibody (acceptor) and at least one CDR is derived from a second antibody (donor), the CDR-grafted antibody being capable of binding to the CD4 antigen; processes for its production; nucleotide sequences for use in its production; compositions containing
    Type: Application
    Filed: January 13, 1999
    Publication date: July 25, 2002
    Inventors: LINDA K. JOLLIFFE, ROBERT A. ZIYIN, VIRGINIA L. PULITO, JOHN R. ADAIR, DILJEET S. ATHWAL